393 related articles for article (PubMed ID: 10209156)
1. Signalling through phosphoinositide 3-kinases: the lipids take centre stage.
Leevers SJ; Vanhaesebroeck B; Waterfield MD
Curr Opin Cell Biol; 1999 Apr; 11(2):219-25. PubMed ID: 10209156
[TBL] [Abstract][Full Text] [Related]
2. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
Steelman LS; Bertrand FE; McCubrey JA
Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
[TBL] [Abstract][Full Text] [Related]
3. PI 3-kinases and PTEN: how opposites chemoattract.
Comer FI; Parent CA
Cell; 2002 May; 109(5):541-4. PubMed ID: 12062096
[TBL] [Abstract][Full Text] [Related]
4. Phosphoinositide signaling in urological disease.
Theodorescu D
J Urol; 2003 Jun; 169(6):2394-6. PubMed ID: 12771804
[No Abstract] [Full Text] [Related]
5. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
[TBL] [Abstract][Full Text] [Related]
6. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals.
Scharenberg AM; El-Hillal O; Fruman DA; Beitz LO; Li Z; Lin S; Gout I; Cantley LC; Rawlings DJ; Kinet JP
EMBO J; 1998 Apr; 17(7):1961-72. PubMed ID: 9524119
[TBL] [Abstract][Full Text] [Related]
8. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
Oudit GY; Sun H; Kerfant BG; Crackower MA; Penninger JM; Backx PH
J Mol Cell Cardiol; 2004 Aug; 37(2):449-71. PubMed ID: 15276015
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling.
Li H; Marshall AJ
Cell Signal; 2015 Sep; 27(9):1789-98. PubMed ID: 26022180
[TBL] [Abstract][Full Text] [Related]
10. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
11. [Involvement of phosphoinositide 3-kinases and phosphoinositide phosphatases in immune responses, glucose metabolism and tumorigenesis].
Sasaki T; Sasaki J; Suzuki A; Penninger JM
Tanpakushitsu Kakusan Koso; 2001 Sep; 46(12):1820-9. PubMed ID: 11552264
[No Abstract] [Full Text] [Related]
12. Signaling pathways of D3-phosphoinositide-binding kinases in T cells and their regulation by PTEN.
Seminario MC; Wange RL
Semin Immunol; 2002 Feb; 14(1):27-36. PubMed ID: 11884228
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and function of 3-phosphorylated inositol lipids.
Vanhaesebroeck B; Leevers SJ; Ahmadi K; Timms J; Katso R; Driscoll PC; Woscholski R; Parker PJ; Waterfield MD
Annu Rev Biochem; 2001; 70():535-602. PubMed ID: 11395417
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
[TBL] [Abstract][Full Text] [Related]
15. Association of INPP1, PIK3CG, and TSC2 gene variants with autistic disorder: implications for phosphatidylinositol signalling in autism.
Serajee FJ; Nabi R; Zhong H; Mahbubul Huq AH
J Med Genet; 2003 Nov; 40(11):e119. PubMed ID: 14627686
[No Abstract] [Full Text] [Related]
16. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.
Vazquez F; Sellers WR
Biochim Biophys Acta; 2000 Feb; 1470(1):M21-35. PubMed ID: 10656987
[No Abstract] [Full Text] [Related]
17. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
Zhang D; Brodt P
Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide phosphatases in a network of signalling reactions.
Blero D; Payrastre B; Schurmans S; Erneux C
Pflugers Arch; 2007 Oct; 455(1):31-44. PubMed ID: 17605038
[TBL] [Abstract][Full Text] [Related]
19. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
